GSK plc ADR buy Citigroup Inc.
Start price
13.02.24
/
50%
€38.80
Target price
13.02.25
-
Performance (%)
-11.86%
End price
14.02.25
€34.20
Summary
This prediction ended on 14.02.25 with a price of €34.20. The prediction for GSK plc ADR disappointed with a performance of -11.86%. Dividends of €1.44 are taken into consideration when calculating the performance. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| GSK plc ADR | 16.972% | 16.972% | 45.714% |
| iShares Core DAX® | 1.085% | -1.655% | 13.297% |
| iShares Nasdaq 100 | -1.665% | -3.137% | 2.218% |
| iShares Nikkei 225® | 3.863% | 6.947% | 22.818% |
| iShares S&P 500 | 0.111% | -1.320% | 1.445% |
Comments by Citigroup_Inc_ for this prediction
In the thread GSK plc ADR diskutieren
GSK plc (NYSE: GSK) was upgraded by analysts at Citigroup Inc. from a "neutral" rating to a "buy" rating.
Ratings data for GSK provided by MarketBeat
In the thread Trading GSK plc ADR
Die von Citigroup_Inc_ gewählte maximale Laufzeit wurde überschritten